Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
No “Constraining Situation” On gVascepa API Says Strides MD, Q3 Revenues Jump
gSuprep Likely To Be Launched In Q4
Feb 09 2024
•
By
Vibha Ravi
Strides Reported A Strong Third Quarter And Expects Generic Vascepa To Add Momentum • Source: Shutterstock
More from Business
More from Scrip